Working Toward FDA Approval for LDN— Jan, 2012

By | LDN info

An excerpt from : The many years of waiting have finally come to an end. Since 1986, when Dr. Bernard Bihari first demonstrated that less than a tenth part of the FDA-approved drug naltrexone could help protect people who had HIV, we have been trying, with only modest success, to persuade the world of science and medicine that LDN is the long-sought “panacea” that can enhance and normalize a…

Read More